Article ; Online: Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II
The Journal of pharmacology and experimental therapeutics
2024 Volume 389, Issue 2, Page(s) 186–196
Abstract: DNA topoisomerase ... ...
Abstract | DNA topoisomerase II |
---|---|
MeSH term(s) | Humans ; Etoposide/pharmacology ; K562 Cells ; DNA Topoisomerases, Type II/genetics ; DNA Topoisomerases, Type II/metabolism ; Mitoxantrone ; CRISPR-Cas Systems/genetics ; Codon, Nonsense ; Antineoplastic Agents/pharmacology ; Leukemia ; DNA ; Phenotype |
Chemical Substances | Etoposide (6PLQ3CP4P3) ; DNA Topoisomerases, Type II (EC 5.99.1.3) ; Mitoxantrone (BZ114NVM5P) ; Codon, Nonsense ; Antineoplastic Agents ; DNA (9007-49-2) |
Language | English |
Publishing date | 2024-04-18 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 3106-9 |
ISSN | 1521-0103 ; 0022-3565 |
ISSN (online) | 1521-0103 |
ISSN | 0022-3565 |
DOI | 10.1124/jpet.123.002038 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Uf I Zs.40: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.